{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-002954","form_type":"8-K","ticker":"FLNA","cik":"0001069530","company_name":"FILANA THERAPEUTICS, INC.","filed_at":"2025-05-08T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.406587+00:00","generated_at":"2026-05-22T02:59:48.788565+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cassava reports Q1 net loss of $23.4M, discontinues Alzheimer's program, pivots to TSC epilepsy","bullets":["Net loss of $23.4M vs net income of $25.0M in Q1 2024; cash and equivalents $117.3M, no debt.","R&D expenses $13.7M (down 16% YoY); G&A $10.9M including $3.0M legal accrual, no insurance recoveries.","Workforce reduced by 10 employees (~33%) in Q1; Alzheimer's program with simufilam to be fully discontinued by end of Q2 2025.","New license from Yale for TSC-related epilepsy; plans to initiate first clinical study in H1 2026.","Appointed Dr. Bordey as SVP Neuroscience and Dr. Moore as SVP Clinical Development; CMO Kupiec retiring May 9."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-002954","json":"https://secwatch.observer/filing/0001171843-25-002954.json","markdown":"https://secwatch.observer/filing/0001171843-25-002954.md","text":"https://secwatch.observer/filing/0001171843-25-002954.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1069530/000117184325002954/0001171843-25-002954-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1069530/000117184325002954/f8k_050825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T02:59:48.788565+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}